奥斯卡健康
OSCR
31.89
-1.58
-4.72%
奥斯卡健康
US · OSCR
#1512 按市值排名
上市于 2021
31.89
-1.58
-4.72%
实时 - 追踪5344个代码 - 心跳于14秒前
· 2026-10-16 20:01
✦ 量化股权信号 计算方式说明
减持
- 最近一期(2026/Q3)披露持股的机构数量增加了4家。
- 机构持股总比例下降了2.2个百分点。
机构持股
- 机构持股比例
- 73.63% -2.16pp
- 机构数量
- 471 +4
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向分歧机构在上一报告期减持了股份,同时该股在最近20个交易日的主力资金呈净流入——两者方向出现分歧。
机构持股变动数据按季度发布且存在滞后;资金流向数据为每日更新。请将其作为方向性的交叉验证参考,而非精确的择时信号。
持股人类型
Mutual Fund42.02%
VC/PE Fund11.82%
Hedge Fund11.57%
Individual/Insider3.85%
Private Company3.74%
Public Company2.63%
Government Pension Fund1.30%
Insurance Company0.30%
Family Office/Trust0.17%
Other22.61%
主要股东 截至 2026-09-18
Thrive Capital Management, LLC
10.66% · 32.86M 股
BlackRock
6.68% · 20.59M 股
T. Rowe Price Group, Inc.
5.28% · 16.29M 股
D. E. Shaw & Co., L.P.
4.10% · 12.64M 股
Vanguard Capital Management, LLC
3.95% · 12.19M 股
Vanguard Portfolio Management, LLC
3.58% · 11.03M 股
American Century Investment Management
2.94% · 9.06M 股
Jane Street Group, LLC
2.06% · 6.37M 股
Mark Bertolini
2.00% · 6.15M 股
Geode Capital Management, LLC
1.89% · 5.82M 股
条形长度是相对于此处列出的最大股东而言,并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 18次买入 · 32次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| Thrive Capital Management, LLC | -- | 10.66% |
| Mark Bertolini | Chief Executive Officer | 2.00% |
| Mario Schlosser | Co-Founder, CTO, President of Technology & Director | 0.78% |
| Richard Blackley | Chief Financial Officer | 0.27% |
| Siddhartha Sankaran | Director | 0.26% |
| Jeffery Boyd | Independent Chairperson | 0.20% |
| Joshua Kushner | Co-Founder & Vice Chairman | 0.15% |
| Victoria Baltrus | Chief Accounting Officer | 0.07% |
| Vanessa Wittman | Independent Director | 0.03% |
| William Gassen | Independent Director | 0.02% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-09-17 | Vanessa Wittman | Independent Director | Automatic Disposition | -25,000 | $32.24 |
| 2026-09-17 | Thrive Capital Management, LLC | -- | Other Acquisition | +6,343,617 | -- |
| 2026-09-17 | Thrive Capital Management, LLC | -- | Other Disposition | -12,687,234 | -- |
| 2026-09-17 | Thrive Capital Management, LLC | -- | Other Disposition | -6,343,617 | -- |
| 2026-09-02 | Janet Liang | EVP & Principal Operating Officer | Automatic Disposition | -10,360 | $31.45 |
| 2026-09-02 | Mario Schlosser | Co-Founder, CTO, President of Technology & Director | Automatic Disposition | -31,422 | $31.45 |
| 2026-09-02 | Richard Blackley | Chief Financial Officer | Automatic Disposition | -28,869 | $31.45 |
| 2026-09-02 | Adam McAnaney | -- | Automatic Disposition | -9,092 | $31.45 |
| 2026-09-02 | Victoria Baltrus | Chief Accounting Officer | Automatic Disposition | -958 | $31.45 |
| 2026-08-27 | Mario Schlosser | Co-Founder, CTO, President of Technology & Director | Derivative Exercise and Sale | -750,000 | -- |
| 2026-08-27 | Mario Schlosser | Co-Founder, CTO, President of Technology & Director | Intent to Sell (Form 144) | -150,000 | $30.79 |
| 2026-08-26 | Mario Schlosser | Co-Founder, CTO, President of Technology & Director | Intent to Sell (Form 144) | -600,000 | $30.34 |
| 2026-08-19 | Jeffery Boyd | Independent Chairperson | Intent to Sell (Form 144) | -288,514 | $33.15 |
| 2026-08-17 | Richard Blackley | Chief Financial Officer | Open Market Disposition | -18,750 | $31.74 |
| 2026-08-12 | Jeffery Boyd | Independent Chairperson | Intent to Sell (Form 144) | -288,513 | $30.11 |
| 2026-08-09 | Jeffery Boyd | Independent Chairperson | Intent to Sell (Form 144) | -134,370 | $28.27 |
| 2026-08-09 | Jeffery Boyd | Independent Chairperson | Intent to Sell (Form 144) | -116,666 | $28.13 |
| 2026-07-08 | Siddhartha Sankaran | Director | Other Derivative Acquisition | +858 | -- |
| 2026-07-08 | William Gassen | Independent Director | Other Derivative Acquisition | +684 | -- |
| 2026-07-08 | David Plouffe | Independent Director | Other Derivative Acquisition | +681 | -- |
Form 4 申报记录,每家公司显示最新的一批。"Other Derivative Acquisition"(其他衍生品获取)类目多为限制性股票/期权归属,并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 20:01:13 · 仅供参考,不构成投资建议,也未考虑您的具体情况。
奥斯卡健康 讨论区 0 条评论